CiVentiChem

Cary, United States Founded: 1994 • Age: 32 yrs Acquired By Sterling Pharma Solutions
Contract research and manufacturing services are offered for pharmaceuticals.

About CiVentiChem

CiVentiChem is a Healthcare company based in Cary (United States) founded in 1994, and was acquired by Sterling Pharma Solutions in April 2019. Contract research and manufacturing services are offered for pharmaceuticals. The company has 81 employees. Its Indian entity Civentichem (India) Private Limited reported revenue of ₹39.15 Cr. CiVentiChem offers products and services including Custom Research Services, Manufacturing Services, and Compound Search. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.

Company details

Founded in 1994 and based in Cary, United States, CiVentiChem operates as a contract development and manufacturing organization in the pharmaceutical sector. Services provided include API and intermediates manufacturing, process development, analytical support, and medicinal chemistry. A portfolio of 13 API products and approximately 2500 compounds is maintained, supporting various research and production needs.

Key Metrics

Products & Services of CiVentiChem

CiVentiChem offers a comprehensive portfolio of products and services, including Custom Research Services, Manufacturing Services, and Compound Search.

Custom Research Services
Research Services

Delivers solutions for complex chemistry problems through specialized research.

Manufacturing Services
Manufacturing

Produces chemical compounds and intermediates for various applications.

Compound Search
Database Services

Enables searching and downloading of chemical compounds for research needs.

Investors in CiVentiChem

CiVentiChem has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sterling Pharma Solutions.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Contract development, manufacturing, and analytical services for APIs are offered.
2016sterlingpharmasolutions.comDudley, United Kingdom
Premium access

Investor details for CiVentiChem

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Civentichem (India) Private Limited (CiVentiChem)

Civentichem (India) Private Limited is the primary company behind CiVentiChem. The board of Civentichem (India) Private Limited currently have 4 directors; the longest-serving is Narasimha Rao Chitineni, appointed in 2004. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Narasimha Rao Chitineni
DIN 00323450
Director20 Feb 200422 yrs 8 moCiventichem (India) Private Limited
Rajnarsing Rao Peechara
DIN 01209897
Director20 Feb 200422 yrs 8 moCiventichem (India) Private Limited
Srinivas Rao Chittineni
DIN 06420234
Managing Director03 Nov 201214 yrsCiventichem (India) Private Limited
Bhaskar Rao Venepalli
DIN 08694224
Director12 Feb 20206 yrs 8 moCiventichem (India) Private Limited

People of CiVentiChem

6 people are tracked at CiVentiChem (2 in leadership, 4 in team); the tracked headcount is 81.

NameRoleGroup
President and CEOLeadership
Krishna Kumar Ramanathan
Director, Chemistry R & DLeadership
Batta Madhavarao
Research ScientistTeam
Muralibabu Kondapalli
Senior Research AssocisteTeam
Samuel Reyes
Research ScientistTeam
Subhash K.
Manager (a.r&d,qc)Team
Premium access

Complete people profiles for CiVentiChem

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of CiVentiChem

Figures of Civentichem (India) Private Limited, the primary company behind CiVentiChem, for FY 2024. Revenue was ₹39.15 Cr (-52% year on year). Net loss was -₹1.06 Cr (-3% margin). EBITDA was ₹2.11 Cr (5% margin). Revenue has grown at a compounded annual rate of -28% over three years and -12% over five years.

  • ₹39.15 CrRevenue · FY 2024 · -52% YoY
  • -₹1.06 CrNet loss · -3% margin
  • ₹2.11 CrEBITDA · 5% margin
  • ₹1.31 CrPaid-up capital
  • 81Employees (provident fund records)
  • -28%Revenue CAGR, 3 years
  • -12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Civentichem (India) Private Limited are on its company page.

Premium access

Detailed financial statements for CiVentiChem

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of CiVentiChem

2 dated milestones of CiVentiChem across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded CiVentiChem is founded.
  2. Exit Acquired by Sterling Pharma Solutions.

Web traffic of CiVentiChem

Websites that share an audience with CiVentiChem (civentichem.com).

Similar websites

Websites whose visitors overlap most with CiVentiChem. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cyclodex.com
100%
#9,755,292View details
acccorporation.com
acccorporation.com
83%
–
npscorp.com
npscorp.com
49%
–

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as CiVentiChem (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Civentichem

Premium access

Complete news archive for CiVentiChem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CiVentiChem

CiVentiChem was founded in 1994.

CiVentiChem is headquartered in Cary, United States. It is registered at Cary, North Carolina, United States.

CiVentiChem has 81 employees.

The primary company behind CiVentiChem, Civentichem (India) Private Limited, reported revenue of ₹39.15 Cr for FY 2024, down 52% year on year.

Founded in 1994 and based in Cary, United States, CiVentiChem operates as a contract development and manufacturing organization in the pharmaceutical sector. Services provided include API and intermediates manufacturing, process development, analytical support, and medicinal chemistry. A portfolio of 13 API products and approximately 2500 compounds is maintained, supporting various research and production needs.

CiVentiChem offers Custom Research Services, Manufacturing Services, and Compound Search.

CiVentiChem has 1 investor. Key investors include Sterling Pharma Solutions.

CiVentiChem operates through Civentichem (India) Private Limited.

Yes. CiVentiChem was acquired by Sterling Pharma Solutions in April 2019.

The legal entities of CiVentiChem currently have 4 directors, including Srinivas Rao Chittineni, Bhaskar Rao Venepalli, Narasimha Rao Chitineni and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available